Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Yelena Korochkina, winner of the 2024 Presidential Prize in Science and Innovation for Young Scientists The prize was awarded for developing innovative methods for the effective implementation of ...

Prof Moffat Nyirenda, Director of the MRC/UVRI and LSHTM Uganda Research Unit, emphasized the importance of collaboration in ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Dr. John Oertle discussed the significance of World Cancer Day, raising awareness about cancer care advancements and ...

The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...

Medlab Middle East is rebranding to WHX Labs Dubai, marking the beginning of a new journey that reflects 24 years of success ...

AI and its potential impact on genomics research and clinical practice was peppered throughout this year's Festival of Genomics ...

The relentless nature of cancer does not mean we are powerless. Medical advancements in precision medicine, immunotherapy, ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...